5830404H04Rik Activators encompass a curated set of chemical compounds that indirectly promote the functional activity of 5830404H04Rikthrough various intracellular signaling pathways, each influencing the protein's activity via distinct mechanistic avenues. Forskolin, by stimulating adenylyl cyclase, raises cAMP levels, thereby activating PKA, which could phosphorylate and enhance the activity of 5830404H04Rik. This enhancement is due to the modification of 5830404H04Rik's phosphorylation state, which is a crucial post-translational mechanism for regulating protein function. Similarly, 1,9-Dideoxyforskolin, via cAMP-independent routes, may promote interactions that lead to the increased activity of 5830404H04Rik. PMA, a potent activator of PKC, may also enhance the activity of 5830404H04Rik through phosphorylation. The calcium ionophores Ionomycin and A23187 elevate intracellular calcium levels, potentially activating calcium-dependent kinases that might phosphorylate and thus augment the activity of 5830404H04Rik. Additionally, db-cAMP, a synthetic analog of cAMP, activates PKA and can modify 5830404H04Rik's activity, while IBMX, by inhibiting the degradation of cAMP, indirectly sustains PKA activity, which is likely to result in an upregulation of 5830404H04Rik's function.
In tandem, other compounds in the activator list function through various signaling pathways to potentiate 5830404H04Rik's activity. EGCG, by inhibiting certain protein kinases, may alter the signaling landscape to favor the activity of 5830404H04Rik. Sphingosine-1-phosphate, via its receptor-mediated signaling, may lead to the activation of pathways that enhance the role of 5830404H04Rik. Staurosporine, though a general protein kinase inhibitor, could, in a counterintuitive manner, enhance the activity of 5830404H04Rik by inhibiting kinases that negatively regulate it. LY294002 and U0126, which modulate the PI3K/AKT and MAPK/ERK pathways respectively, may rebalance signaling networks in a way that indirectly favors 5830404H04Rik activation. Collectively, these compounds, through their diverse and targeted effects on cellular signaling, facilitate the heightened functional activity of 5830404H04Rik without direct interaction, emphasizing the intricate web of intracellular signaling that governs protein functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate a range of substrates, potentially including 5830404H04Rik, thereby enhancing its activity through post-translational modification. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that may phosphorylate and thus enhance the activity of 5830404H04Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that, like Ionomycin, raises intracellular calcium levels and can therefore indirectly activate calcium-dependent kinases that might increase the functional activity of 5830404H04Rik. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
db-cAMP is a cell-permeable cAMP analog that can activate PKA. PKA phosphorylation can alter the function and activity of downstream proteins such as 5830404H04Rik. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP. By preventing cAMP degradation, IBMX indirectly increases the activity of PKA, which may then enhance the activity of 5830404H04Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit several protein kinases. This inhibition can lead to altered signaling pathways, potentially upregulating the activity of 5830404H04Rik by affecting the phosphorylation status or protein-protein interactions. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors and can influence a variety of signaling pathways. Through these pathways, S1P may indirectly enhance the activity of 5830404H04Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, but paradoxically, it can enhance the activity of some proteins by inhibiting their negative regulators. Staurosporine could enhance 5830404H04Rik activity by this mechanism. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/AKT signaling pathway. By modulating this pathway, LY294002 could indirectly enhance the activity of 5830404H04Rik by affecting downstream signaling components. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that interferes with the MAPK/ERK pathway. Although it is generally used to reduce the activity of this pathway, it could also rebalance the cellular signaling environment to favor the activation of 5830404H04Rik. | ||||||